Egypt’s health ministry has given the state-run Therapeutic Institution one month to seal a deal handing the University of Vienna control of Heliopolis Hospital for the next 15 years, under a plan that would double the hospital’s bed count and inject 1.2 billion Egyptian pounds in fresh investment.
The agreement, once finalized, will go before the Cabinet for approval, a Health Ministry source told Al Manassa on condition of anonymity.
Under the terms being drawn up, the hospital's capacity would rise from 200 to 400 beds. A new building would go up on adjoining land, a stalled second building would finally be completed, and the existing facility would be overhauled. Egyptian medical teams would also be sent abroad to train in the university's treatment protocols.
In mid-July, the health minister held a meeting with the University of Vienna to review the hospital development and management project, attended by CCO board chair Mohamed Shweikar. The ministry described the venture as an “integrated academic and medical partnership,” with a particular focus on pediatrics and its subspecialties.
Under the proposed split, 60% of beds would go to patients treated at state expense or through health insurance, with the remaining 40% reserved for paying patients and medical tourists. The university would also introduce organ transplants and cancer surgery, and build out training programs in chest and orthopedic surgery, the source said.
Financially, the Therapeutic Institution would take an annual cut of 9% of the hospital’s total revenue — or a minimum of 24 million pounds — with that share climbing by 1% every three years.
Abdel Ghaffar has also insisted the university secure accreditation from Egypt's General Authority for Healthcare Accreditation and Regulation within three years of taking over, a requirement for joining the country's Universal Health Insurance system. The university would additionally need Joint Commission International (JCI) accreditation to strike deals with foreign insurers and draw in international patients.
The University of Vienna, for its part, has asked to keep 70% of the hospital's current staff, with the rest redistributed to other Therapeutic Institution facilities — a request the institution has accepted, according to the source.
The arrangement falls under Law No. 87 of 2024, which allows Egyptian or foreign investors to take over management of state health facilities for up to 15 years with Cabinet sign-off, provided they maintain the facility, reserve a share of services for state-funded and insured patients, and return all assets to the state once the contract ends.
Guarantees matter more than the price tag
Alaa Ghanam, who heads the Right to Health unit at the Egyptian Initiative for Personal Rights, has cautioned against judging the partnership purely on its investment figures or bed numbers.
What matters more, he told Al Manassa, is whether the contract protects the state's ownership of the hospital, its control over pricing, and its ability to police the quality of care.
Any private-sector partnership, he argued, should be judged on three counts: whether it cuts costs for the state, whether prices stay stable for patients, and whether patients are satisfied with their care. A profitable operator or a lighter financial burden on the state means little, he warned, if patients or service quality suffer as a result.
He pointed to Gustave Roussy International-Egypt Hospital — formerly known as Hermel — as a cautionary tale. The facility eased pressure on state finances, he said, but also saw costs rise for some patients without a matching improvement in satisfaction, even as its operator turned a profit.
The Health Ministry signed that deal in February 2025 with Elevate Health, exclusive Egyptian partner of France's Gustave Roussy Institute, turning Hermel into the institute's first branch outside France. Under that arrangement, 70% of beds went to state-funded and insured patients, with 30% set aside for paying patients.
Since the new management took over, patients have complained of medicine shortages, being asked to pay out of pocket for drugs, and cuts to state-funded chemotherapy.
Ghanam wants the Heliopolis contract to avoid the same pitfalls, calling for a binding clause requiring — ideally annual — reviews of the contract's terms and results, so that any problems with pricing, service quality, or the operator's obligations to state-funded patients can be caught early.
Part of a wider push
The Heliopolis deal is the latest step in a broader government drive to move public hospital management into private hands. Al Manassa has previously reported that the government plans to offer more than 40 hospitals to local and foreign investors, building on earlier deals — including Gustave Roussy’s takeover of the Dar El-Salam Oncology Center, known as Hermel, and the Nasr City Association’s management of Maadi Mabarra Hospital.
That push has drawn concern over service prices, job security for hospital staff, and how well these management contracts are policed. A previous Al Manassa investigation into the Maadi Mabarra deal found the initial offer gave the operator management rights for ten years in exchange for just 6% of revenue — with a floor of three million pounds a year — while keeping on only half the hospital’s staff.
The same investigation uncovered a conflict of interest at the heart of the deal: the association was chaired by Ahmed Saafan, who at the time also served as assistant health minister for hospital affairs and head of the Therapeutic Sector overseeing government hospitals — the very role that approved the association’s direct appointment in March 2024. After the investigation was published, the ministry revised the contract, raising the Therapeutic Institution’s revenue share to 8%, with a minimum of ten million pounds a year.
